MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Programming for Freezing of gait after Bilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease

H. Zheng, F. Sun, L. Zhang (Nanjing, China)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Proof-of-Principle Quantitative EEG Study of CX-8998, an Oral, Potent and Selective T-Type Calcium antagonist in development for symptomatic treatment of Essential Tremor and Parkinson’s disease Tremor

S. Papapetropoulos, M. Lee, S. Boyer (Cambridge, MA, USA)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Propionibacterium acnes Infection with Intracerebral Abscess in Deep Brain Stimulation

R. Lewis, F. Farrokhi, M. Marsans (Seattle, WA, USA)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Propofol-induced acute dystonic reaction after orthopedic surgery in a young healthy woman

R. Barbosa, M. Salavisa, M. Mendonça (Lisbon, Portugal)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
PROtein, LEucine And vitamin D Enhancing Rehabilitation (PRO-LEADER) in patients with Parkinson’s disease or parkinsonism: A RCT

M. Barichella, E. Cereda, G. Pinelli, L. Iorio, D. Caroli, I. Masiero, V. Ferri, E. Cassani, C. Bolliri, S. Caronni, P. Ortelli, D. Ferrazzoli, A. Maras, G. Riboldazzi, G. Frazzitta, G. Pezzoli (Milano, Italy)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Public Awareness on Parkinson’s disease in Urban Central Asia

O. Turgunkhujaev, F. Aliyeva, A. Khashimova, A. Mukanova, O. Okhunov, S.H. Ikramova, A.H. Tan, S.Y. Lim (Moscow, Russian Federation)

Education in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Pulvinar low intensity on susceptibility-weighted imaging may predict cognitive worsening after deep brain stimulation therapy in Parkinson’s disease patients

K. Matsuura, M. Maeda, M. Satoh, K. Tabei, T. Araki, M. Umino, H. Kajikawa, N. Nakamura, H. Tomimoto (Tsu, Mie, Japan)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Putative treatment of Parkinson’s Disease using extract of Bacopa monnieri

S. Sinha, P. Kumar (Allahabad, India)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Quality of Life in Tic Disorders: An Observational, Mainstream School-Based Population Study over Time

E. Casas-Peña, B. Ouyang, Y. Liu, E. Cubo, K. Kompoliti (Burgos, Spain)

Tics/Stereotypies  ·  Hall 3FG
1:45pm-3:15pm
Quantifying the Reproducibility of an In Vivo Assay: Examination of Historical Amantadine Effects in the macaque Model of L-DOPA-Induced Dyskinesia

E. Pioli, P. Stanley, W. Ko, Q. Li, R. Kozak, P. Popiolek, E. Bezard (Manchester, United Kingdom)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 59
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley